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1. Introduction 
We have previously shown that the serum HDL** 
of Macacus rhesus, when compared to human serum 
HDL, exhibits imilar, though not identical chemical 
and physical properties [ 1, 2]. Of particular structural 
relevance was the observation that apo A-II, one of 
the two major polypeptides of HDL, is present in the 
rhesus as a monomer, contrary to the dimeric form oc- 
curring in man [3, 6]. This difference was found to be 
related to the replacement in the rhesus of cysteine 
by serine in position 6 from the NH2-terminus [3, 4]. 
Amino acid data of apo-II indicated additional differ- 
ences in the two animal species [3]. Based on this in- 
formation, and on the potential significance of such 
studies from the evolutionary standpoint, an investi- 
gation was undertaken on the definition of the prima- 
ry structure of rhesus apo A-II. We have isolated and 
characterized the cyanogen bromide fragments of both 
rhesus and human apo A-II. In this communication we 
present the results of such studies and compare them 
with information presented in the literature [6, 7]. 
* Operated by the University of Chicago for the U.S. Atomic 
Energy Commission. 
** Abbreviations u ed: HDL, high density lipoproteins of
d 1.063-1.21 g/ml; apo HDL, delipidated apoprotein from 
HDL; apo-II, one of the two major apoproteins of HDL - 
equivalent tofraction IV or apo LP Gln-II (12); CNBr, 
cyanogen bromide; PCA, pyrrolidone carboxylic acid; 
PCAse, pyrrolidone carboxylic acid peptidase; SCMC, 
S-carboxymethyl-cysteine. 
2. Materials and methods 
2.1. Source and isolation o f  apo A-1I 
Blood was obtained by plasmapheresis from a sin- 
gle male monkey (Macacus rhesus) maintained on a 
Purina Primate Chow low-fat diet. The serum HDL 
was isolated by ultracentrifugal flotation between 
solvent densities of 1.063 and 1.21 g/ml and tested 
for contamination by agarose gel electrophoresis and 
by immunodiffusion techniques [2]. The apoprotein 
apo HDL was obtained by delipidation [8] and then 
fractionated by DEAE-ion exchange column chroma- 
tography as previously described [3]. By such a pro- 
cedure apo A-II was obtained in pure form and as- 
sessed by polyacrylamide g l electrophoresis, by its 
reactivity against monospecific antisera nd by amino 
acid composition which was identical to that previous- 
ly reported [3]. The isolation of apo A-II from human 
donors was carried out as described before [9]. 
2.2. CNBr cleavage 
Cleavage at the methionyl residue of apo A-II was 
performed in 70% formic acid at room temperature. 
A 500-fold molar excess of CNBr to methonine was 
added, and the reaction was allowed to proceed in a 
sealed vessel under nitrogen for 48 hr [7]. Following 
incubation, the sample was diluted 10-fold with dis- 
tilled water and the excess reagents were removed by 
lyophilization. The percentage of methionine that 
remained uncleaved never exceeded 20%, as checked 
by amino acid analysis. 
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2.3. Chromatographic separation of CNBr fragments 
After treatment with CNBr, apo A-II was separated 
by gel f'fltration on a column (1.5 X 200 cm) of Sepha- 
dex G-50 (superfine; Pharmacia Fine Chemicals, 
Piscataway, N.J.). The equilibrating and eluting buffer 
was 0.05 M Tris-HC1-8 M urea, pH 8.2, pumped as- 
cendingly at 6 ml/hr in a constant-temperature room 
kept at 8°C. The eluate was continuously monitored 
by absorbance at 280 nm on an ISCO optical unit 
(Instrumentation Specialities Co., Lincoln, Neb.). The 
eluted peptide fractions were desalted on a column 
(2.5 X 45 cm) of Sephadex G-10 equilibrated in 0.05 M 
N-ethyl morpholine-acetate buffer, pH 8.3. Purity 
of the isolated fractions was determined by amino 
acid analysis, polyacrylamide g l electrophoresis, and 
COO H- and NH2-terminal analysis. These procedures 
were described previously [3]. The isolated peptides 
were lyophilized and stored at -20°C. 
2.4. Other procedures 
PCAse, kindly provided by Dr. R.E. Fellows of 
Duke University, was used to unblock amino terminus 
of one of the CNBr fragments [3]. The released PCA 
was identified as its silylated erivative by gas-liquid 
chromatography as previously described [3]. Molecu- 
lar weights were estimated from amino acid analysis. 
Protein concentrations were determined by the Lowry 
procedure [10] and by amino acid analysis. In the case 
of human apo A-II, reduction and alkylation [5] were 
carried out after cleavage with CNBr, and the products 
were chromatographed as described above. Sequencing 
was performed on an automatic Beckman Model 890 
Sequencer. The released amino acids were detected as 
their phenylthiohydantoin and silylated derivatives by 
gas-liquid chromatography (Beckman GC Model 45) 
and by thin layer chromatography using the solvent 
system of Jeppson and Sj6quist [ 1 I]. 
3. Results 
3.1. Macacus rhesus 
Fig. 1 shows the elution profile of CNBr-treated 
apo A-II from a Sephadex G-50 column in the pres- 
ence of 8 M urea. Three major peaks were eluted, 
designated as B, C and D. A fourth minor peak, A, 
which was recovered in less than 1% yield, will not be 
considered here. Peak B was the fraction that resisted 
CNBr cleavage as assessed by amino acid data and 
NH 2- and COOH-terminal analyses. Peaks C and D 
represented the two CNBr fragments. 
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Fig. 1. Sephadex G-50 chromatography of CNBr-cleaved rhesus and reduced and alkylated human apo A-II. The conditions were: 
column dimensions, 1.5 X 200 cm; eluting buffer, 0.05 M Tris-HCl, 8 M urea, pH 8.0, at 8°C; amount of sample, 15-20 mg pro- 
tein; flow rate, 6 ml/hr. 
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Fig. 2. Gas-liquid chromatographic tracings of trimethylsilyl 
pyroglutamie acid. A, Standard; B, PCAse-treated CNBr frag- 
ment D from rhesus apo A-II. 
Fragment C had 52 amino acid residues, a mol.wt. 
of 5917, and the NH2-terminal sequence: Glu-Lys-  
Val-Lys-Ser-Pro .... By carboxypeptidase A-diges- 
tion, the COOH-terminal residue was glutamine, which 
is the same as in the parent molecule [3, 4]. In addi- 
tion, this fragment contained no homoserine, homo- 
serine lactone, methionine or isoleucine, and had a 
single residue of arginine. 
Fragment D had 26 amino acid residues and a 
mol.wt, of 2950. The NH2-terminus was blocked. 
PCAse digestion released PCA, which was detected 
as its silylated erivative by gas-liquid chromatogra- 
phy (fig. 2). Edman's degradation ofPCAse-treated 
fragment D gave the following partial sequence: 
PCA-Ala-Glu-Glu-Pro-Ser-Val .... Fragment D
also contained 0.82 moles of homoserine and homo- 
serine lactone per mole of pepfide, indicating that it 
was the NH2-terminal CNBr peptide. 
The overaU information on the two CNBr fragments, 
C and D, summarized in table 1, permitted thier align- 
ments as indicated in fig. 3. 
3.2. Man 
The elution profile of the CNBr-treated, reduced 
and carboxymethylated apoA-II was the same as ob- 
served with the corresponding rhesus product (fig. 1). 
The two human CNBr fragments has properties iden- 
tical to those reported by Lux et al. [6, 7] and differ- 
ed from the rhesus fragments as summarized in table 
1 and fig. 3. 
4. Discussion 
The present studies have shown that CNBr cleavage 
of the single methionine residue of Macaeus rhesus apo- 
protein II yields two peptides which differ in size and 
composition and are readily separable from each other 
by column chromatography. In addition, methionine 
was found to occupy position 26 from the NH2-termi- 
nus; this was also the case for the human apo A-II 
Rhesus  
FRAGMENT D FRAGMENT C 
I I I I 
3 , 6 26 27 77  7e 
...... c "° PCA-  A Io  -~G~:'-  Glu - P ro -S~r -  Val  Met  - Glu - Lys  - vo l  - Lys  - Ser  - P ro  Thr  - Gin - . 
OH 
Human PCA - A la  - Lys  -G lu  - P ro -  SCMC-Va l  Met  - Glu - Lys -Vo l  - Lys  - Ser f  P ro  
re  7r  0 
Thr  - Gin - C ~' 
"OH 
Fig. 3. Alignment of peptides of rhesus and human apo A-II derived from the results of the present study. 
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Table 1 
Chemical properties of CNBr fragments from rhesus apo A-II and reduced and alkylated human apo A-II. 
1 
Rhesus Human 
CNBr fragments CNBr fragments CNBr fragments 
Apo A-II Apo A-II Apo A-II 
Amino acid C D C+D R&A C D C+D R&A C-III C-IV 
This study Ref. [9] This study Refs. 16, 7] 
Residues/mole* 
Aspartic** 2 2 4 4 3 1 2 3 3 1 2 
Threonine*** 4 2 6 6 6 4 2 6 6 4 2 
Serine*** 3 3 6 6 6 4 2 6 6 4 2 
Glutamic** 11 6 17 17 16 11 5 16 16 11 5 
Proline 3 1 4 4 4 3 1 4 4 3 1 
Glycine 1 1 2 2 3 2 1 3 3 2 1 
Alanine 5 1 6 6 5 4 1 5 5 4 1 
Valine 4 3 7 7 6 3 3 6 6 3 3 
Methionine 0 0 0 1 1 0 0 0 1 0 0 
Isoleucine 0 0 0 0 1 1 0 1 1 1 0 
Leucine 6 2 8 8 8 6 2 8 8 6 2 
Tyrosine 2 2 4 4 4 2 2 4 4 2 2 
Phenylalanine 3 1 4 4 4 3 1 4 4 3 1 
Lysine 7 1 8 8 9 7 2 9 9 7 2 
Arginine 1 0 1 1 0 0 0 0 0 0 0 
Carboxymethylcystine 0 0 0 0 1 0 1 1 1 0 1 
Homoserine 0 1 1 0 0 0 1 1 0 0 1 
Homoserine lactone 
Histidine 0 0 0 0 0 0 0 0 0 0 0 
Tryptophan 0 0 0 0 0 0 0 0 0 0 0 
Totalnumber of residues 52 26 78 78 77 51 26 77 77 51 26 
Molecularweightt 5917 2950 8867 8867 8690 5710 2950 8690 8690 5710 2950 
NH:~-terminal Glu PCA - PCA PCA Glu PCA - PCA Glu Unre. 
COOH-terminal Gin Unre. - Gin Gin Gin Unre. - Gin - - 
* The values were adjusted to the nearest integer. 
** The value represents he sum of aspartic acid and asparagine or glutamic acid and glutamine. 
** * Corrected for lo ss during hydroly sis. 
t From amino acid composition. 
R & A = reduced and alkylated. 
monomer,  a f'mding corroborating previous reports 
[_6, 7]. The apo-II monomers from rhesus and man 
were previously shown to contain nearly the same 
number of  amino acid residues, 78 and 77, respective- 
ly [3]; the current study now indicates that, upon 
CNBr cleavage, both monomers  yield a minor (26 res- 
idues) and a major (52 and 51 residues, respectively) 
fragment, the minor one occupying the NH2-terminal 
region of  the parent molecule and the major, the 
COOH-terminal port ion (fig. 3). In spite of  the observ- 
ed structural analogies, chemical differences in apo 
A-II were observed between rhesus and man, and these 
differences were reflected in both of  the CNBr frag- 
ments. The minor peptide ( f ra~nent  D) was of  partic- 
ular interest: in the rhesus, serine occupied position 
6 from the blocked NH2-terminus, whereas in man 
this residue was replaced by cysteine (table 1 and fig. 3). 
This observation, which supports previous results ob- 
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tained with the intact rhesus apo A-II [3], accounts 
for the existence of apo A-II monomers in rhesusHDL 
and of dimers in human HDL [2, 4, 6, 7]. 
The chemical differences which have been observed 
between the apo A-II of rhesus and man (more work 
in this direction is in progress in the laboratory) are of 
relevance not only from the viewpoint of HDL struc- 
ture but also from an evolutionary aspect. Macacus 
rhesus and man occupy a distinct position in the phylo- 
genetic tree; thus, a chemical comparison of their lipo- 
protein polypeptides may permit an assessment of the 
evolutionary distance of these two animal species. In 
this context, it is of interest hat the baboon, which 
belongs to the same family as the rhesus monkey, has, 
like the latter, apo A-II monomers in its HDL class [3]. 
The chimpanzee, the closest ancestor to man, in turn, 
exhibits apo A-II dimers [ 13]. 
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